AIDS could soon be history. Johnson & Johnson recently announced plans to test an experimental HIV vaccine in the United States, South America, and Europe. It’s already conducting a clinical trial of ...

NEW YORK - DECEMBER 1: Marina Kemelman, Research Associate at the AIDS Vaccine Design and Development Laboratory, collects bacteria transfected with DNA as part of research at the laboratory's campus ...

More than 40 years of AIDS research has led to significant advancements in treatment and prevention. Drugs to treat the infection continued to improve, as did patient outcomes. But now there's another ...

This essay is part of a First Opinion series on the future of the National Institutes of Health and American science. In 1984, during my intern year, I admitted the first of what would become ...

The most meaningful HIV cure will be not only safe and effective but also widely accessible for the 39 million people infected worldwide, no matter who they are or where they live. Hans-Peter Kiem, MD ...

Thought LeadersDr. Larry CoreyProfessor and President and Director EmeritusFred Hutch Cancer Center To commemorate World AIDS Day, News Medical spoke to Dr. Larry Corey, an internationally renowned ...

Just over 40 years ago, the first case of acquired immunodeficiency syndrome—more commonly known as AIDS—was reported, setting into motion a worldwide panic about the unknown, devastating disease. At ...

Current HIV research aims to cure or eliminate the infection. Although people can manage HIV effectively with treatment, scientists are focusing on cures in several future directions. HIV is a virus ...

The founding chairman of The Foundation for AIDS Research (amfAR), Mathilde Krim, died Monday (January 15). She was 91. When the first cases of AIDS were reported in 1981, Krim, then the director of ...